Guardant Health's Shield Blood Test Now Covered for VA Community Care Beneficiaries
US veterans and eligible family members now have access to blood test for colorectal cancer screening with no copay
Benefit will cover all eligible individuals ages 45-84, representing first coverage beyond Medicare population for Shield
PALO ALTO, Calif., March 25, 2025--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield™ blood test for colorectal cancer (CRC) screening is now covered by a key healthcare insurance program for U.S. veterans. The screening test is covered for patients receiving community care authorized by the U.S. Department of Veterans Affairs (VA) as an in-network benefit, with no copay for average-risk individuals who are age 45 or older.
Following Medicare coverage for Shield in August 2024, the VA network coverage is the first for individuals between the ages of 45 and 64. The U.S. Department of Veterans Affairs (VA) Community Care Network (CCN) consists of community-based practitioners who provide veterans with healthcare services and covers approximately 9.1 million beneficiaries.1
"We are proud of the lifesaving value that the Shield blood test can bring to U.S. veterans and their families," said AmirAli Talasaz, Guardant Health co-CEO. "This coverage decision by the VA is the first for younger and non-Medicare beneficiaries and we are excited to broaden the impact of our screening test to help detect more colorectal cancer early, when it is most treatable."
The U.S. Food and Drug Administration (FDA) approved Shield in July 2024 as the first blood test for primary CRC screening, and the Centers for Medicare & Medicaid Services (CMS) recently approved Advanced Diagnostic Laboratory Test (ADLT) status for Shield for colorectal cancer screening.
The Shield blood test is FDA approved for primary non-invasive screening for colorectal cancer in average-risk individuals age 45 and older and can be ordered by any prescribing healthcare provider. For more information, visit www.ShieldCancerScreen.com.
About Guardant Health
Guardant Health is a leading precision oncology company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care and accelerating new cancer therapies by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and treatment selection for patients with advanced cancer. For more information, visit guardanthealth.com and follow the company on LinkedIn, X (Twitter) and Facebook.
Guardant Health Forward-Looking Statements
This press release contains forward-looking statements within the meaning of federal securities laws, including statements regarding the potential utilities, values, benefits and advantages of Guardant Health's liquid biopsy tests or assays, which involve risks and uncertainties that could cause the actual results to differ materially from the anticipated results and expectations expressed in these forward-looking statements. These statements are based on current expectations, forecasts and assumptions, and actual outcomes and results could differ materially from these statements due to a number of factors. These and additional risks and uncertainties that could affect Guardant Health's financial and operating results and cause actual results to differ materially from those indicated by the forward-looking statements made in this press release include those discussed under the captions "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operation" and elsewhere in its Annual Report on Form 10-K for the year ended December 31, 2024, and any current and periodic reports filed with or furnished to the Securities and Exchange Commission thereafter. The forward-looking statements in this press release are based on information available to Guardant Health as of the date hereof, and Guardant Health disclaims any obligation to update any forward-looking statements provided to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, except as required by law. These forward-looking statements should not be relied upon as representing Guardant Health's views as of any date subsequent to the date of this press release.
References1. https://www.data.va.gov/dataset/VetPop2023-State-Data-6L/f43c-vb9n/data_preview
View source version on businesswire.com: https://www.businesswire.com/news/home/20250325726184/en/
Contacts
Investor Contact: Zarak Khurshidinvestors@guardanthealth.com
Media Contact: Michael Weistpress@guardanthealth.com +1 317-371-0035
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Miami Herald
an hour ago
- Miami Herald
Jaguar Health to Conduct Fireside Chat June 10 Regarding Company's Efforts to Further its Orphan Disease Development Programs as Part of Lytham Partners' Spring 2025 Spotlight Series
Click here to register SAN FRANCISCO, CA / ACCESS Newswire / June 6, 2025 / Jaguar Health, Inc.(NASDAQ:JAGX) today announced that Lisa Conte, the company's founder, president and CEO, will participate in a virtual fireside chat at 9:00 AM Eastern on Tuesday, June 10, 2025, as part of Lytham Partners' spring 2025 Spotlight Series. The discussion will focus on Jaguar's ongoing efforts to further its orphan disease development programs. Participation Instructions for Jaguar Health's Virtual Fireside Chat During Lytham Partners Spring 2025 Spotlight Series When: Tuesday, June 10, 2025 from 9:00 - 10:00 AM Eastern Where: Online (Click Here). The fireside chat will also be available for replay following the event. About the Jaguar Health Family of Companies Jaguar Health, Inc. (Jaguar) is a commercial stage pharmaceuticals company focused on developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for people and animals with gastrointestinal distress, specifically associated with overactive bowel, which includes symptoms such as chronic debilitating diarrhea, urgency, bowel incontinence, and cramping pain. Jaguar family company Napo Pharmaceuticals (Napo) focuses on developing and commercializing human prescription pharmaceuticals for essential supportive care and management of neglected gastrointestinal symptoms across multiple complicated disease states. Napo's crofelemer is FDA-approved under the brand name Mytesi® for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. Jaguar family company Napo Therapeutics is an Italian corporation Jaguar established in Milan, Italy in 2021 focused on expanding crofelemer access in Europe and specifically for orphan and/or rare diseases. Jaguar Animal Health is a Jaguar tradename. Magdalena Biosciences, a joint venture formed by Jaguar and Filament Health Corp. that emerged from Jaguar's Entheogen Therapeutics Initiative (ETI), is focused on developing novel prescription medicines derived from plants for mental health indications. For more information about: Jaguar Health, visit Napo Pharmaceuticals, visit Napo Therapeutics, visit Magdalena Biosciences, visit Visit the Make Cancer Less Shitty patient advocacy program on Bluesky, X, Facebook & Instagram Forward-Looking Statements Certain statements in this press release constitute "forward-looking statements." These include statements regarding Jaguar's expectation that Jaguar management will participate in a virtual fireside chat June 10, 2025 as part of Lytham Partners' spring 2025 Spotlight Series. In some cases, you can identify forward-looking statements by terms such as "may," "will," "should," "expect," "plan," "aim," "anticipate," "could," "intend," "target," "project," "contemplate," "believe," "estimate," "predict," "potential" or "continue" or the negative of these terms or other similar expressions. The forward-looking statements in this release are only predictions. Jaguar has based these forward-looking statements largely on its current expectations and projections about future events. These forward-looking statements speak only as of the date of this release and are subject to several risks, uncertainties, and assumptions, some of which cannot be predicted or quantified and some of which are beyond Jaguar's control. Except as required by applicable law, Jaguar does not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise. Contact: hello@ SOURCE: Jaguar Health, Inc.
Newsweek
an hour ago
- Newsweek
VA Marks Benefits Milestone For Veterans
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. The Department of Veterans Affairs (VA) has announced that its mobile app has now accumulated more than 3 million downloads since its launch in 2021. The Health and Benefits app, which has 1.4 million active users, provides veterans access to information on health care and benefits. It allows users to refill and track VA prescriptions, review appointments, review claims and appeals status, submit evidence for claims and appeals, review VA payment and direct deposit information, locate the closest VA facilities, access the Veterans Crisis Line and show proof of Veteran status. VA Acting Assistant Secretary for Information and Technology and Acting Chief Information Officer Eddie Pool said: "VA's Health and Benefits app gives Veterans fast and convenient access to a host of important information, from appointments to prescriptions and benefits. We encourage all VA-enrolled Veterans to stay connected and informed by downloading the app." File photo: the Department of Veterans Affairs building in Washington. File photo: the Department of Veterans Affairs building in Washington. Charles Dharapak/AP This story will be updated.
Yahoo
an hour ago
- Yahoo
How Trump broke the politics of Medicaid
Republicans used to cheer the possibility of Medicaid cuts. Now, as the GOP advances President Donald Trump's 'Big Beautiful Bill' that would reduce Medicaid spending, they're rebranding it as making the program stronger. The shift reflects the striking new politics of Medicaid — and how dramatically the GOP's coalition has changed under Trump. Now Democrats are hoping Medicaid could be the issue that exposes the cracks in the Trump coalition. They have seized on a nonpartisan Congressional Budget Office estimate that the bill would cause 7.8 million people to lose access to the low-income health insurance program. At stake is whether Democrats can start to win back working-class voters who have shifted toward the GOP over the past decade. Medicaid provides health insurance for nearly 80 million people but was long the electoral forgotten sibling of Social Security and Medicare. It's clear in the ads: TV ads for House and Senate races last election cycle were 26 times as likely to mention Medicare, the health care program for seniors, as Medicaid, according to a POLITICO analysis of transcripts from AdImpact, which tracks political advertising. But that's already changing. 'I saw elections 16 years ago where people ran on cutting Medicaid, and there were folks who were on Medicaid who were in the crowd cheering them on,' said Kentucky Gov. Andy Beshear, a potential Democratic candidate for president in 2028. 'That's not the case of where we are today.' The Medicaid provisions in the GOP's budget bill have prompted new debate even among Republicans. To Beshear and others, that provides an opening. Democrats, he said, should stand in front of hospitals and 'talk about how important Medicaid is,' he said, while emphasizing 'the impact on specific communities.' Congressional Democrats have seized on the issue, with moderates and progressives alike speaking in defense of the program. The party's House campaign arm is prioritizing Medicaid in swing-district messaging. And TV ads mentioning Medicaid have already run in more Republican-held districts this year than they did all of last cycle. Republicans are cautious, with an ideologically diverse group of senators wary of cuts and poised to exert significant influence over the bill. Sen. Josh Hawley (R-Mo.), who warned that cutting the program would be 'both morally wrong and politically suicidal,' said last week that Trump had promised him no cuts to benefits. GOP lawmakers have largely rallied around Trump's bill by arguing the House legislation protects Medicaid by only removing people who do not deserve it in the first place. That careful messaging is a stark difference from a decade ago, when congressional Republicans explicitly prioritized cutting Medicaid and governors blocked its expansion. One reason for the turnaround: A series of red states expanded Medicaid by ballot initiative between 2017 and 2020 — largely with backing of Democratic-aligned groups — and GOP voters defied their state and local political leaders in large numbers to support the program. Nationwide, enrollment for Medicaid and the Children's Health Insurance Program rose from just shy of 70 million in 2014 to nearly 79 million at the end of 2024. And at the same time more people were entering the program, including Republican voters in red states, an electoral realignment was shifting working-class voters toward Trump. 'Medicaid has a broader and broader appeal the more people that are on it, and the more people who know someone who's on it. That's incredibly powerful politically,' said Kelly Hall, executive director of the Fairness Project, which backed state Medicaid referendums. The makeup of Medicaid users was changing — and so were its politics. For a long time, the program has been relatively absent from federal races. Even in the 2018 midterms, when defending the Affordable Care Act was central to Democrats' midterm messaging, only 30 TV ads across all congressional elections mentioned Medicaid, while nearly 500 mentioned Medicare, POLITICO's analysis found. But Medicaid expansion was a major issue in many gubernatorial and state legislative races in the 2010s. The success of ballot measures proved the program had a strong constituency, even in red states. And Trump's popularity with working-class voters also reshaped the GOP's coalition. Compared to Republican candidates before him, Trump's 2024 gains were strongest in counties with high Medicaid enrollment, a POLITICO analysis found. In the 2024 election, 49 percent of Medicaid recipients voted for Trump compared to 47 percent for Kamala Harris, according to Morning Consult polling. That means cuts to Medicaid or reductions in eligibility could now pose a political risk for Republicans. People who could lose benefits would not just be Democratic voters in blue states, but Republicans in red states and swing districts who supported Trump last year. Drew Kent, a GOP strategist whose firm recently polled Pennsylvania's voters, found a slight majority, including 30 percent of Republicans, disapproved of work requirements for Medicaid. 'These results are definitely a bit surprising to me,' Kent said. 'It clearly shows the challenges and importance, particularly in a political swing state like Pennsylvania, of getting the policy, messaging, and communications right on an issue of this magnitude.' Republicans are aware of the potential political liability: The GOP's argument about the bill, which could still face changes in the Senate, is that the changes to the program do not amount to cuts for voters. 'The President wants to preserve and protect Medicaid for the Americans who this program was intended for,' White House Press Secretary Karoline Leavitt said at a press briefing last month. 'We want to see able-bodied Americans at least working 20 hours per week, whether that's part-time or full-time, whether that's even looking for work or volunteering for 20 hours a week, if they are receiving Medicaid.' A memo from the National Republican Campaign Committee last month advised the party to go on offense, saying the bill protects Medicaid by 'removing illegal immigrants and eliminating fraud.' Among its provisions, the bill would penalize states such as California that use state dollars to extend Medicaid benefits to undocumented immigrants. According to CBO estimates, of the nearly 11 million people who would lose Medicaid or other health insurance due to the bill, about 1.4 million are immigrants. GOP strategist Josh Novotney argued that approach is in line with what Trump's working-class base wants. "Most blue-collar Trump supporters I have met or spoken with in large groups do not want their hard-earned taxes going to other people, whether that is student debt forgiveness or Medicaid abuse," he said. "That is not at odds with his supporters." A Kaiser Family Foundation poll released Friday found a plurality of Republicans, 42 percent, believed the Trump administration's policies would strengthen Medicaid, with only 22 percent believing the program would be weakened. But Republican Medicaid enrollees were more split, with 35 believing Trump would strengthen the program and 34 percent saying he would weaken it. That is where Democrats see an opening. A nonprofit affiliated with Democrats' House campaign arm is already targeting swing-district Republicans with digital ads accusing members of cutting Medicaid to pay for tax breaks for the rich. And a flurry of other liberal groups have purchased TV or digital ads and planned billboards and other activist campaigns. 'To the extent that this is becoming a bigger political issue, it's simply because their efforts to destroy Medicaid are fundamentally more dangerous and more real than ever before,' said Sen. Chris Murphy (D-Conn.), whose PAC is helping fund a group that opposes Medicaid cuts. As the bill currently stands, the Medicaid work requirements would not go into effect until the end of 2026. That means Democrats largely won't be able to point during their midterm campaigns to people who have already lost access to Medicaid. Instead, they may rely on voter trust on an issue that has historically worked for them. While polls have found voters consistently prefer the GOP more on issues such as the economy and immigration — which helped propel Trump's win last year — health care has remained a rare bright spot for Democrats. 'If there is a debate or chaos or uncertainty about Medicaid cuts, then I think Democrats stand to benefit from that because of the brand advantage on health care,' said Democratic pollster Zac McCrary. 'One of the few places where we have maintained an edge.'
